BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events

  December 24, 2025

   · 

  4 min read
• Press Releases

  Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

  December 24, 2025

   · 

  7 min read
• Press Releases

  Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

  December 24, 2025

   · 

  7 min read
• Press Releases

  BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

  December 24, 2025

   · 

  1 min read
• Press Releases

  Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

  December 24, 2025

   · 

  4 min read
• Press Releases

  Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6

  December 24, 2025

   · 

  5 min read
• Press Releases

  CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

  December 24, 2025

   · 

  4 min read
• Press Releases

  Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

  December 24, 2025

   · 

  3 min read
• Press Releases

  Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

  December 24, 2025

   · 

  6 min read
• Press Releases

  Immuneering to Announce 12-Month Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on January 7, 2026

  December 24, 2025

   · 

  4 min read